JW
Jim Wassil (EVP, Chief Scientific Ofc, COO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $1.6M of PCVX (18,000 sh × $86.74, as filed), executed Oct 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $87.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
PCVXRecent filings
PCVXSALE
Vaxcyte, Inc.
View filing →
$571K6,839 sh across 2 lots
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $740K
8,000 sh across 3 lots
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $760K
7,129 sh across 2 lots
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET